John Mullaly | Investor Relations |
Jennifer Bath | President and Chief Executive Officer |
Lisa Helbling | Chief Financial Officer |
Greetings. Thank you for standing by. Welcome to the ImmunoPrecise First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note this conference is being recorded.